These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection. Meitert E; Sima F; Savulian C; Petrovici M; Chersulick E; Costache G Arch Roum Pathol Exp Microbiol; 1989; 48(3):237-51. PubMed ID: 2519634 [TBL] [Abstract][Full Text] [Related]
10. [Experimental immunological effectiveness and safety of pyoimmunogen vaccine against Pseudomonas aeruginosa infection]. Stanislavskiĭ ES; Ioo I; Severtsova MK; Mashilova GM; Boltutsiĭ LG Zh Mikrobiol Epidemiol Immunobiol; 1982 May; (5):70-5. PubMed ID: 6808791 [TBL] [Abstract][Full Text] [Related]
11. The epidemiology of Pseudomonas aeruginosa and the development of a polyvalent vaccine. Pranter W; Staerk J; Zellner R; Zwisler O Prog Immunobiol Stand; 1971; 5():414-8. PubMed ID: 4633968 [No Abstract] [Full Text] [Related]
12. [Cell-free Pseudomonas vaccine. IV. Laboratory trials of the effectiveness of experimental Pseudomonas vaccines]. Stanislavskiĭ ES; Joó I; Bulk VF; Zhvanetskaia MI; Mashilova GM Zh Mikrobiol Epidemiol Immunobiol; 1982 Oct; (10):25-9. PubMed ID: 6817559 [TBL] [Abstract][Full Text] [Related]
13. [Combined Staphylococcus-Proteus-Pseudomonas vaccine. II. The toxicity of the vaccine in "chronic" experiments and its ability to protect animals against Proteus and Staphylococcus infections]. Kreĭnin LS; Egorova NB; Stanislavskiĭ ES; Kaverina KG; Levina LA Zh Mikrobiol Epidemiol Immunobiol; 1983 May; (5):87-92. PubMed ID: 6410625 [TBL] [Abstract][Full Text] [Related]
14. Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia. Pennington JE; Pier GB; Sadoff JC; Small GJ Rev Infect Dis; 1986; 8 Suppl 4():S426-33. PubMed ID: 2944209 [TBL] [Abstract][Full Text] [Related]
15. Pseudomonas aeruginosa. II. Experimental acellular vaccine of an endotoxin and anatoxin type. Bĕlohlávek S; Pavlík V; Rencová J; Stránský V; Nováková L; Sourek J; Výmola F J Hyg Epidemiol Microbiol Immunol; 1987; 31(3):343-52. PubMed ID: 3119704 [TBL] [Abstract][Full Text] [Related]
16. [Development of immunological preparations and their use for preventing and treating pyocyanic infection in burn patients]. Kolker II; Stanislavskiĭ ES; Grishina IA; Panova IuM; Krokhina MA Probl Gematol Pereliv Krovi; 1981 Jan; 26(1):29-33. PubMed ID: 6784114 [No Abstract] [Full Text] [Related]
17. [Comparative study of the antibody concentration and protective activity against Pseudomonas aeruginosa of gamma-globulin and IgM-enriched immunoglobulin preparations]. Kiseleva IA; Kandiurina VG; Timofeeva GV Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):68-71. PubMed ID: 2424197 [TBL] [Abstract][Full Text] [Related]